NGAL is a Novel Target in Hypertension by Modulating the NCC-Mediated Renal Na Balance.
Benjamin BonnardSoumaya El MoghrabiKohei UedaLionel LattenistMatthieu SoulieNatalia Lopez-AndreésConstance XhaardTatsuo ShimosawaPatrick RossignolFrédéric JaisserPublished in: Hypertension (Dallas, Tex. : 1979) (2023)
we highlight a novel role of NGAL/lcn2 as a modulator of the activity of the renal sodium transporter NCC affecting salt-sensitive blood pressure.